Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Michelle Fay Cortez - When Hardcore Pharma Investors Meet Enthusiastic Oncologists
When Hardcore Pharma Investors Meet Enthusiastic Oncologists
Bloomberg –

This article is for subscribers only. Welcome back to Bloomberg's Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you're not already on the list. The…

chron.com - BridgeBio Pharma: Q3 Earnings Snapshot
BridgeBio Pharma: Q3 Earnings Snapshot
Chron –

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $56.7 million in its third quarter. The Palo Alto, California-based company said it had a loss of 42 cents per share. The…

swissinfo.ch - swissinfo.ch - Pharma companies continue to pay millions to doctors
Pharma companies continue to pay millions to doctors
www.swissinfo.ch –

In 2025, these payments – in the form of conference attendance fees, accommodation expenses, fees and consultancy fees – totalled CHF234 million ($283 million). This figure is CHF28 million lower than in 2024, but the decline is…

econotimes.com - Celia Rowan - The Economic Times Reports Sun Pharma Above Its 20-day Average
The Economic Times Reports Sun Pharma Above Its 20-day Average
EconoTimes –

The Economic Times reported Sun Pharmaceutical Industries Limited (Sun Pharma) shares above a reported 20-day simple moving average in early trading Oct. 30, the date set for a board meeting to consider and approve results. In its 11:46:26 p.m. ET…

cnbc.com - Harvey Stober - West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
CNBC –

West Pharmaceutical Services once again showed that it's more than just a GLP-1 play. Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. On Thursday, the stock hit a 52-week high in the wake of a…

fool.com - Thomas Niel - Should You Buy Royalty Pharma Stock Before Nov. 4?
Should You Buy Royalty Pharma Stock Before Nov. 4?
The Motley Fool –

Royalty Pharma (RPRX +1.64%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring back…

nypost.com - Emily Fu - Embattled Purdue Pharma exec ordered to stop blocking sale of mansion to fund opioid settlements
Embattled Purdue Pharma exec ordered to stop blocking sale of mansion to fund opioid settlements
New York Post –

Former Purdue Pharma chairman Richard Sackler was ordered stop interfering with the sale of his sprawling Connecticut mansion — as the Sackler family's $7.4 billion opioid settlement threatens to cost him one of his luxury homes. A federal…

thehindu.com - N. Ravi Kumar - Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown
Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown
The Hindu –

India's pharmaceutical exports rose 4.90% year-on-year (YoY) to $16.14 billion in the first half of FY27, as strong demand from Europe, Latin America and ASEAN markets offset a decline in shipments to North America, including the crucial U.S.

politico.eu - Carlo Martuscelli - Belgium's deputy PM wants to use 'trade bazooka' on US over pharma threats
Belgium's deputy PM wants to use 'trade bazooka' on US over pharma threats
POLITICO –

The Trump administration has been pressuring European governments to pay more for medicines under its “most-favored-nation” policy as it seeks to bring American drug prices into line with those in other wealthy countries. Washington…

swissinfo.ch - swissinfo.ch - Swiss stock market climbs to new all-time high
Swiss stock market climbs to new all-time high
www.swissinfo.ch –

On Thursday, the blue-chip stocks provided support for the SMI. Shares in the pharmaceutical group Novartis rose by 2% at around 9:50 am, those of the food giant Nestlé by 1% and those of the pharmaceutical company Roche by 0.5%. By…

marketbeat.com - aTyr Pharma (NASDAQ:ATYR) Sees Large Volume Increase - Here's Why
aTyr Pharma (NASDAQ:ATYR) Sees Large Volume Increase - Here's Why
MarketBeat –

Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) saw an uptick in trading volume on Thursday. Approximately 111,433 shares were traded during mid-day trading, an increase of 78% from the average daily volume of 62,656 shares. The stock…

swissinfo.ch - swissinfo.ch - Swiss railways plans CHF7 billion digital upgrade
Swiss railways plans CHF7 billion digital upgrade
www.swissinfo.ch –

The mid-terms and democracy, a new national park, and political hamburgers Read more: The mid-terms and democracy, a new national park, and political hamburgers Switzerland, China and Germany's mistakes Read more: Switzerland, China and Germany's…

rediff.com - Nandita Malik - Indian Stock Market Rally: Sensex, Nifty Gain on IT Sector & Trent Earnings
Indian Stock Market Rally: Sensex, Nifty Gain on IT Sector & Trent Earnings
Rediff.com –

Indian benchmark indices Sensex and Nifty continued their upward trajectory in early trade, propelled by robust buying in the IT sector and significant gains from Trent following its impressive September quarter earnings report. Sensex climbed…

afaqs.com - Pawan Kulkarni - Do brands age? Rajinikanth has a lesson for marketers
Do brands age? Rajinikanth has a lesson for marketers
afaqs! –

Amitabh Bachchan once said in a film, “Mooche ho to Nathulal ji jaise ho, warna na ho.” In the same spirit, we could say, “Superstar ho to Rajinikanth jaise ho, warna na ho.” Am I just another one of his countless fans?

bloomberg.com - Ashutosh Joshi - India's Small Investors Dump Stocks, Chase New Listings
India's Small Investors Dump Stocks, Chase New Listings
Bloomberg –

This article is for subscribers only. I'm Rajesh Mascarenhas in Mumbai, where stock traders will be hoping to finish the week on a high. The benchmark Nifty 50 capped its best day in two weeks on Thursday. As disappointing earnings from some of the…

Receive a Daily briefing on Pharma Industry News

Get Started